With the introduction of direct-acting antivirals (DAAs), treatment against hepatitis C virus (HCV)
has significantly improved. To manage and control this worldwide infectious disease …

The scientific community is focused on developing antiviral therapies to mitigate the impacts
of the ongoing novel coronavirus disease 2019 (COVID-19) outbreak. This will be facilitated …

Antiviral treatments targeting the coronavirus disease 2019 are urgently required. We
screened a panel of already approved drugs in a cell culture model of severe acute respiratory …

Viruses causing chronic infection artfully manipulate infected cells to enable viral
persistence in vivo under the pressure of immunity. Human T-cell leukemia virus type 1 (HTLV-1) …

Antiviral treatments targeting the emerging coronavirus disease 2019 (COVID-19) are
urgently required. We screened a panel of already-approved drugs in a cell culture model of …

Background Development of an effective antiviral drug for Coronavirus Disease 2019 (COVID-19)
is a global health priority. Although several candidate drugs have been identified …

The incubation period, or the time from infection to symptom onset, of COVID-19 has usually
been estimated by using data collected through interviews with cases and their contacts. …

Background: During the COVID-19 outbreak, facility capacity for HIV testing has been limited.
Furthermore, people may have opted against HIV testing during this period to avoid COVID-…

The scientific community is focussed on developing antiviral therapies to mitigate the impacts
of the ongoing novel coronavirus disease (COVID-19) outbreak. This will be facilitated by …

In the current era of antiviral drug therapy, combining multiple drugs is a primary approach for
improving antiviral effects, reducing the doses of individual drugs, relieving the side effects …